Generative Artificial Intelligence (AI) Meets Healthcare - New Prescription

Pharma and healthcare sectors are getting a tech makeover with generative AI. From crunching massive data sets for R&D breakthroughs to mimicking human speech for improved patient care, this technology is making waves. the publisher latest Innovation Radar report "New prescription: generative AI meets healthcare" unveils the transformative potential of the technology backed by real-world innovations, spanning drug discovery, diagnostics, and clinical documentation. Data privacy and human oversight remain hurdles, but they're not stopping this tech revolution.

Innovations: presents real-world innovation examples related to the generative AI use cases in the pharma and healthcare sectors. It casts light on how pharma sector players are utilizing generative AI technology across key sector-specific application areas.

Scope

• Innovation Insights: innovation examples by generative AI use cases in the pharma and healthcare sector to present key trends.

Reasons to Buy

• No surprise that technology has been a driving force in business transformation for years, but the term ‘emerging technologies’ has all of a sudden become the key catalyst to drive the next wave of innovation across sectors.
• The sense of urgency weighs differently across different sectors, where the direct customer-facing sectors are at the forefront compared to other capital-intensive sectors. Companies in one sector can take cues from successful innovations in other sectors to either draw analogies with existing products, services, and processes or transfer strategic approaches for a revolutionary transformation.
• Against this backdrop, enterprises need to understand which emerging technologies are impacting their sector and how various companies are implementing them to meet various challenges.
• The innovation landscape report on pharma and healthcare innovations in generative AI, released by the publisher as part of an ongoing series, covers some real-world examples to advance the development and implementation of the technology by some of the key enterprises in the pharma and healthcare sector.